• About
  • Team
  • funds
    • o2h human health KI EIS
    • o2h human health SEIS
    • o2h human health EIS
  • Portfolio
  • Documents
  • news
    • news
    • Press releases
    • Blog
    • Press Coverage
    • Events
  • Login
  • Contact

o2h-ventures

  • About
  • Team
  • funds
    • o2h human health KI EIS
    • o2h human health SEIS
    • o2h human health EIS
  • Portfolio
  • Documents
  • news
    • news
    • Press releases
    • Blog
    • Press Coverage
    • Events
  • Login
  • Contact

Don’t invest unless you’re prepared to lose all your money invested. This is a high risk investment. You could lose all the money you invest and are unlikely to be protected if something goes wrong. Take 2 mins to learn more

Knowledge intensive investing… a new investment era
Knowledge intensive investing… a new investment era
Dec 9 2020

 

The only certain outcome of the COVID-19 pandemic is to vindicate the value of investing in  biomedicine. Vaccines will be made, treatments will be found, and the social and financial value of medical scientists and innovation will be proven again.

Biotechnology and Healthcare are proving to be amongst the top performing investment sectors over the last decade, particularly at a time when their importance has never been more clear. 

In April 2020 the UK government acknowledged the importance of knowledge intensive companies and more importantly the importance of funding them. The introduction of Knowledge Intensive EIS funds allows UK research and development to get the investment it needs to help generate significant impact for British business.

Knowledge intensive firms have tended to have had the hardest time in scaling-up, particularly in their early phases but the new regulations should aid this process.  The introduction of knowledge intensive EIS investing will only strengthen the government’s continued efforts to finance the growth of innovative firms across the UK and seed investment as part of a portfolio is a fantastic social, ethical and financial addition.

EIS-KnowledgeIntensive-fund-o2hventures

So… What is knowledge intensive investing

The key is innovation… and the UK is in a very privileged position to be rich in life science, biotechnology and technology ideas, to generate numerous university spinouts,  that will fully meet the knowledge intensive criteria.

In order to meet knowledge intensive guidelines, a business must meet a number of criteria, including a team of skilled employees, defined innovation and potential product or platform  thresholds  A project needs to be assessed on its own quality and merits and the ability to perform this due diligence is key.

As well as having a pool of highly skilled academic core with the potential to create and secure a high value intellectual property rich backbone, therapeutics, biotechs and AI and are at the forefront of research and development.  By accessing capital these businesses can create high quality jobs and have the potential to create revenues that add to the overall wealth and prosperity of the UK economy.

Investing in this early stage research and development is opening up access to some of the most exciting opportunities in the UK.

What are the benefits to the Investor…

EIS investing in the UK is key to innovation and growing British businesses in order to create jobs, generate tax and put the UK at the forefront of new ideas.

As well as the government approved EIS tax reliefs, knowledge intensive investing is treated in the tax year in which the fund closes even if the investments are actually made in the next year and of course can be carried back to the previous year.

In addition, investors can claim tax relief on up to £2m per annum, if at least £1m of this is invested in the knowledge intensive companies.

And the Benefits to the company…

Knowledge intensive companies can receive more funding over a longer period of time.

As well as receiving double the amounts of EIS funding per year (£10milliion) extended trading time limits (up to 10) and changes in commercial sale and turnover limits, opens the field for UK knowledge intensive, research and development and home grown talent to take the center stage.

o2h ventures is the perfect fit…

At o2h ventures we are in an exciting position to meet the criteria for knowledge intensive investing to nurture early stage biotech therapeutics & AI assets through seed investment, working alongside and investing in companies that can look to generate returns (financial, social and ethical) for investors as part of the post seed and early finance cycle.

As a group we seed new ideas in science, technology and social enterprise.  Knowledge intensive investing is the core of our approach in working across boundaries, nurturing and developing innovation, collaborating and seeding some of the most exciting opportunities across our extensive network.

Bringing knowledge intensive investing to life is a really exciting world to be in. 

 

Connect with us
  • linkedin
  • twitter
  • instagram
  • facebook
  • youtube
o2h-ventures
related stories
  • Oct 2022, o2h Ventures Fund Newsletter, KI EIS Closing, EISA events 1 November, 2022
  • Aug-Sept 2022, o2h Ventures Fund Newsletter, fifty percent of our companies led by female and more portfolio updates 30 September, 2022
  • July 2022, o2h Ventures Fund Newsletter, Deals executed in Alevin Therapeutics, Neurofenix, Five Alarm Bio 1 August, 2022
o2h-ventures
The o2h team are leaders in the biotech community and have been actively involved as investors, holding various board/industry positions as well as being engaged in grassroots scientific activity for over 20 years.
Useful Links
  • About Us
  • Blog
  • Documents Centre
  • Contact Us
  • Team
News
  • Oct 2022, o2h Ventures Fund Newsletter, KI EIS Closing, EISA events
  • Aug-Sept 2022, o2h Ventures Fund Newsletter, fifty percent of our companies led by female and more portfolio updates
  • July 2022, o2h Ventures Fund Newsletter, Deals executed in Alevin Therapeutics, Neurofenix, Five Alarm Bio
Connect with us
  • linkedin
  • twitter
  • instagram
  • facebook
© 2023 o2h ventures
  • Privacy Policy
  • Blog
  • Contact us
o2h ventures Limited is regulated and authorised by the Financial Conduct Authority (FRN 812245). Capital at risk, only suitable for high net worth and sophisticated investors

Risk Information

Due to the potential for losses, the Financial Conduct Authority (FCA) considers this investment to be high risk

What are the key risks?

1 – You could lose all the money you invest

• If the business you invest in fails, you are likely to lose 100% of the money you invest. Most start-up businesses fail.

2 – You are unlikely to be protected if something goes wrong

• Protection from the Financial Services Compensation Scheme (FSCS), in relation to claims against failed regulated firms, does not cover poor investment performance. Try the FSCS investment protection checker here. (https://www.fscs.org.uk/check/investment-protection-checker)

• Protection from the Financial Ombudsman Service (FOS) does not cover poor investment performance. If you have a complaint against an FCA-regulated firm, FOS may be able to consider it. Learn more about FOS protection here. (https://www.financial-ombudsman.org.uk/consumers)

3 – You won’t get your money back quickly

• Even if the business you invest in is successful, it may take several years to get your money back. You are unlikely to be able to sell your investment early.

• The most likely way to get your money back is if the business is bought by another business or lists its shares on an exchange such as the London Stock Exchange. These events are not common.

• If you are investing in a start-up business, you should not expect to get your money back through dividends. Start-up businesses rarely pay these.

4 – Don’t put all your eggs in one basket

• Putting all your money into a single business or type of investment for example, is risky. Spreading your money across different investments makes you less dependent on any one to do well.

• A good rule of thumb is not to invest more than 10% of your money in high-risk investments (https://www.fca.org.uk/investsmart/5-questions-ask-you-invest)

5 – The value of your investment can be reduced

• The percentage of the business that you own will decrease if the business issues more shares. This could mean that the value of your investment reduces, depending on how much the business grows. Most start-up businesses issue multiple rounds of shares.

• These new shares could have addition rights that your shares don’t have, such as the right to receive a fixed dividend, which could further reduce your chances of getting a return on your investment.

If you are interested in learning more about how to protect yourself, visit the FCA’s website here (https://www.fca.org.uk/investsmart)